Jacques Souquet, Founder and CEO of SuperSonic Imagine, is Elected to the National Academy of Technologies of France

Regulatory News :

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814), a company specializing in ultrasound medical imaging (sonography), announces that Jacques Souquet, Founder and CEO of SuperSonic Imagine, has been elected to the National Academy of Technologies of France in December 2014¹.

In early March, under the dome of the Palais de la Découverte in Paris, the fourteen new members of the National Academy of Technologies were inducted in a formal ceremony.

The National Academy of Technologies is a national, public establishment under the supervision of the Minister of Research. Its mission is to deliberate and formulate proposals, and advise on questions related to technologies and their societal interaction. There are 298 elected members, chosen for their excellence and accomplishments in their professional domain in Europe and outside.

"We are very pleased to welcome Jacques Souquet into the National Academy of Technologies. Jacques Souquet will bring his experience for all matters related to the development of medical devices in France, their impact on health care economics, patient benefits and growth. His top-level expertise in scientific development and research will be very valuable in understanding the rapidly expanding world of medical devices.” explains Alain Bugat President of the National Academy of Technologies.

"It is a great honor for me to be part of the National Academy of Technologies. I share their motto: "For a reasoned shared chosen progress”. I am convinced that technological evolution in medicine is a source of progress for all of humanity.” concludes Jacques Souquet.

Biography - Jacques Souquet

An engineer of Supelec, a prestigious French institution, Ph.D. graduate of Stanford University, Jacques Souquet completed his thesis on non-destructive testing which allows the characterization of structures and materials without degradation. In 1978, he created his first company " KYS, Inc.” and sold the technology to a company that created a microscope combining visual optics and acoustics. In 1981, he joined ATL Ultrasound, an American company based in Seattle, where he successfully occupied various posts such as Scientific Director of Cardiology, Strategic Marketing/Product Development Director, Vice-President of Product Generation, and finally Director of Scientific Research and Technology. It was at that moment that the idea of a portable ultrasound machine came to maturation. In 1996, he then created a second company, SonoSite, which grew to a worldwide installed base of 90,000 ultrasound devices and became the third largest ultrasound company in the United States. SonoSite was later purchased by Fujifilm for 1 billion dollars.
From 2000 to 2005, he joined Philips Medical and became Director of Research and Scientific Development and Worldwide Senior Vice-President. In 2005, Jacques Souquet founded Supersonic Imagine, an ultrasound medical imaging company that markets a revolutionary ultrasound platform. The company entered the stock market in April 2014. Jacques Souquet holds 10 patents in the field of acoustic imaging. He is the inventor of the multiplane transesophageal echo probe, which is still widely used in echocardiography examinations.

For more information about the National Academy of Technologies:
http://www.academie-technologies.fr/en/

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about Supersonic Imagine, visit www.supersonicimagine.com

¹ See news of the National Academy of Technologies of France